Zymeworks Inc
NYSE:ZYME
Zymeworks Inc
Accounts Payable
Zymeworks Inc
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zymeworks Inc
NYSE:ZYME
|
Accounts Payable
$6.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Accounts Payable
$29.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
25%
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Accounts Payable
$2.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Accounts Payable
$1.9m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Accounts Payable
$5.7m
|
CAGR 3-Years
37%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
15%
|
|
Spectral Medical Inc
TSX:EDT
|
Accounts Payable
CA$2.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
See Also
What is Zymeworks Inc's Accounts Payable?
Accounts Payable
6.2m
USD
Based on the financial report for Dec 31, 2023, Zymeworks Inc's Accounts Payable amounts to 6.2m USD.
What is Zymeworks Inc's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
19%
Over the last year, the Accounts Payable growth was -21%.